Author
Listed:
- Alison F. Smith
(Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds)
- Mike Messenger
(Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds; National Institute of Health Research (NIHR) Diagnostic Evidence Cooperative (DEC) Leeds, UK)
- Peter Hall
(Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK)
- Claire Hulme
(Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds)
Abstract
Introduction: Numerous factors contribute to uncertainty in test measurement procedures, and this uncertainty can impact on the downstream clinical utility and cost-effectiveness of testing strategies. Currently however, there is no clear guidance concerning if or how such factors should be considered within Health Technology Assessments (HTAs) of tests. Aim: To provide an introduction to key concepts in measurement uncertainty and explore, via systematic review, current methods utilised within HTAs for the assessment of measurement uncertainty. Methods: HTAs of in-vitro tests including a model-based economic evaluation were identified via the Centre for Reviews and Dissemination (CRD) HTA database, HTA authority websites and citation checking. Data extraction was conducted to explore the specific components of measurement uncertainty assessed and methods utilised, and results were narratively synthesised.Results: Of 107 identified HTAs, 20 (19%) attempted to assess components of measurement uncertainty: 15 included an ‘intermediate’ assessment (e.g. literature review or laboratory survey); 4 also included components within the economic model; and 1 considered measurement uncertainty within the model only. The specific components assessed and methods adopted differed across studies. In particular, several techniques were employed within the economic models to incorporate data on test agreement, total error or biological and analytical variability. Conclusion: Various approaches have been adopted within a minority of HTAs to attempt to capture the impact of measurement uncertainty on test outcomes; uncertainty remains around when such assessments are required and appropriate methodology for conducting analyses, particular within economic evaluations.
Suggested Citation
Alison F. Smith & Mike Messenger & Peter Hall & Claire Hulme, 2017.
"The role of measurement uncertainty in Health Technology Assessments (HTAs) of in-vitro tests,"
Working Papers
1705, Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds.
Handle:
RePEc:lee:wpaper:1705
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:lee:wpaper:1705. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Judy Wright (email available below). General contact details of provider: https://edirc.repec.org/data/heleeuk.html .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.